Clicky

Johnson & Johnson(JNJ) News

Date Title
Jul 14 Kenvue Seeks Its Own Band-Aid With CEO Departure and Strategic Review. The Stock Rises.
Jul 14 Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors
Jul 14 Pre-Markets in the Red to Start a Fresh Week
Jul 14 Big Week of Inflation Data, Q2 Earnings Reports
Jul 14 Zimmer to acquire Monogram Technologies for $177 million, boosting robotics portfolio
Jul 14 Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure
Jul 14 Should J&J Stock Be in Your Portfolio Ahead of Q2 Earnings?
Jul 14 Kenvue CEO Departs As Company Launches Strategic Review
Jul 14 Kenvue CEO Mongon leaves the consumer health company as it continues its strategic review
Jul 14 Stocks Decline Pre-Bell Amid Tariff Tensions; Investors Await Inflation Data, Earnings
Jul 6 J.P. Morgan Maintained Their Hold Rating on Johnson & Johnson (JNJ)
Jul 4 These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Jul 4 North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE
Jul 4 Goldman Sachs Rates Johnson & Johnson a Buy, Citing Pipeline Strength and Policy Tailwinds
Jul 3 Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again
Jul 3 The Zacks Analyst Blog Highlights Johnson & Johnson, The Home Depot, Micron Technology, Autoscope Technologies and Nova LifeStyle
Jul 3 Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?
Jul 3 Johnson & Johnson submits application to the European Medicines Agency seeking indication extension of AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer ...
Jul 3 MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE
Jul 3 Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma